Sun Pharmaceutical Industries Ltd., one of India’s leading global pharmaceutical companies, has announced the appointment of Mr. Kirti Ganorkar as the new Managing Director, effective immediately.
Mr. Ganorkar, who has played a pivotal role in Sun Pharma’s global operations and strategy, brings over two decades of industry experience to the role. His appointment signals a continued focus on sustainable growth, innovation, and global expansion.
Mr. Dilip Shanghvi, the company’s founder and longstanding leader, will continue in his role as Executive Chairman of the Board, providing strategic oversight and long-term vision for the company.
This leadership transition reflects Sun Pharma’s commitment to strengthening its governance framework while continuing its journey as a global leader in specialty generics and complex therapies.
The Board congratulates Mr. Ganorkar on his new role and expresses confidence in his leadership as the company enters its next phase of growth and innovation.
